Skip to product information
1 of 3

BPC-157 + TB-500 Blend

BPC-157 + TB-500 Blend

Regular price £50.00
Regular price Sale price £50.00
Sale Sold out
Taxes included. Shipping calculated at checkout.

Multi-buy savings: save 4% on 2+ items and 6% on 3+. Applied automatically in your cart.

Size
Type

Quantity
  • Same-day dispatch on orders before 2pm, Royal Mail Tracked
  • Free UK shipping on orders over £100
  • Certificate of Analysis with every order · View CoA
  • For in vitro laboratory research use only

Certificate of Analysis · BPC-157 + TB-500 Blend

Open full size

Sample certificate for this product. Your order includes the certificate for your batch. Tap an image to zoom.

BPC-157 + TB-500 Blend Certificate of Analysis - Peptide Biosciences UK
BPC-157 + TB-500 Blend Certificate of Analysis, image 2 - Peptide Biosciences UK
Concentration calculator
Concentration–
Molarity–

For laboratory calculation only. Not for human or veterinary use.

BPC-157 + TB-500 is a research peptide combination pairing two of the most widely published peptides in preclinical literature. BPC-157 (CAS 137525-51-0) is a gastric-derived pentadecapeptide studied for angiogenesis, GI mucosal biology and connective-tissue models. TB-500 (the active actin-sequestering fragment of Thymosin β4; parent compound CAS 107761-42-2) is studied for cellular migration, actin dynamics and angiogenesis.

The two are studied together because of their complementary mechanisms: BPC-157 primarily through NO-system modulation and growth factor signalling, and TB-500 through actin sequestration and LKKTETQ-domain-mediated cell migration. Available in 10 mg and 20 mg formats.

Research areas

  • Combined pathway studies
  • Angiogenesis
  • Musculoskeletal models
  • GI mucosal biology
  • Cardiomyocyte models
  • Cellular migration

BPC-157 CAS: 137525-51-0 · TB-500 (Thymosin β4) CAS: 107761-42-2 · Purity: ≥99% HPLC (each component) · Format: Lyophilised powder blend · Storage: −20 °C.

Research Use Only. Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.

View full details